63446-38-8

Usage

Uses

Used in Pharmaceutical Industry:
3-methyl-6,7-dihydro-1H-indazol-4(5H)-one is used as a raw material or intermediate for the synthesis of more complex compounds, particularly in the development of pharmaceuticals. Its unique structure and properties make it a valuable component in the creation of new drugs and therapeutic agents.
Used in Biochemical Research:
In the field of biochemistry, 3-methyl-6,7-dihydro-1H-indazol-4(5H)-one serves as a key intermediate in laboratory settings, facilitating the synthesis of various biochemical compounds. Its presence in these reactions contributes to the advancement of scientific understanding and the discovery of novel biochemical applications.
Used in Chemical Synthesis:
3-methyl-6,7-dihydro-1H-indazol-4(5H)-one is utilized as a building block in chemical synthesis processes, allowing for the creation of a wide array of organic compounds with diverse properties and functions. Its role in these syntheses is crucial for the development of new materials and compounds with potential applications across various industries.

Upstream product

• 4056-73-9 2-acetyl-1,3-cyclohexanedione 
• 302-01-2 hydrazine 

Downstream Products

• 96546-41-7 3-Methyl-4,5,6,7-tetrahydro-1H-indazol-4-ol 

Relevant academic research and scientific papers

SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF

The present invention covers substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular and renal diseases, as a sole agent or in combination with other active ingredients.

HETEROTRICYCLIC COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention relates to novel compounds of Formula (I), wherein wherein X1, X2, Y, Z1, Z2, Z3, M and (A)m are defined as in Formula (I); invention compounds are modulators of metab

Synthesis and structural study of tetrahydroindazolones

Multinuclear magnetic resonance spectroscopy allowed us to characterize four 1(2),5,6,7-tetrahydro-4H-indazol-4-one derivatives (1-4) and establish the most stable tautomer in each case. The crystal structure of 6,6-dimethyl-1(2),5,6,7-tetrahydro-4H-indaz

SYNTHESIS OF ANGULAR BENZODIPYRAZOLES AND RELATED SYSTEMS

A series of benzodipyrazoles was prepared from cyclohexane-1,3-dione.Several related systems with different central rings were also prepared.In addition, benzodipyrazoles were synthesized from 1,4-cyclohexanedione monoethylene

Dipyrazoles and their use as bronchodilators

A group of variously methyl-substituted[1,2-c:3,4-c']dipyrazoles, cyclohepta[1,2-c:3,4-c']dipyrazoles, and cyclopenta[1,2-c:3,4-c']dipyrazoles useful as bronchodilators are described herein. The compounds are prepared by reacting a 1,3-diketone with hydra

Cycloalkane[1,2-c:4,3-c']dipyrazoles and their use as bronchodilators

The present invention is directed to a group of methylated tetrahydro cyclohepta[1,2-c:4,3-c']dipyrazoles and benzo[1,2-c:4,3-c']dipyrazoles useful as bronchodilators. The compounds are prepared by the reaction of an appropriate hydrazine with an appropri